TiumBio Co., Ltd. (KOSDAQ:321550)
South Korea flag South Korea · Delayed Price · Currency is KRW
6,210.00
0.00 (0.00%)
At close: Jun 5, 2026

TiumBio Revenue

TiumBio had revenue of 2.95B KRW in the quarter ending March 31, 2026, with 40.07% growth. This brings the company's revenue in the last twelve months to 13.13B, up 90.14% year-over-year. In the year 2025, TiumBio had annual revenue of 12.29B with 80.92% growth.

Revenue (ttm)
13.13B
Revenue Growth
+90.14%
P/S Ratio
14.20
Revenue / Employee
n/a
Employees
n/a
Market Cap
186.54B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202512.29B5.50B80.92%
Dec 31, 20246.79B1.89B38.65%
Dec 31, 20234.90B-4.22B-46.27%
Dec 31, 20229.12B9.06B15,952.75%
Dec 31, 202156.80M-992.15M-94.59%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
ISU Abxis58.94B
NIBEC32.34B
Genome & Company24.02B
CORESTEMCHEMON18.39B
Prestige Biologics18.03B
Bio Solution15.82B
Kangstem Biotech3.42B
Y-Biologics2.79B
Revenue Rankings